Medscape Family MedicineCOMMENTARY Mauricio Wajngarten, MD DISCLOSURES | August 20, 2024 Edema in the feet and legs is a common complaint in our practices. It can cause pain, weakness, heaviness, discomfort, limited movement, and a negative body image. Medications can contribute to edema, either alone or in combination with other health issues. Edema is also...
Category: <span>Editorial</span>
Post
Sugar Substitutes, Originally Meant to Reduce Health Risk, May Wreak Havoc on Gut Microbiomes
Medscape Diabetes & EndocrinologyCOMMENTARY Brandy W. Root, RDN DISCLOSURES | August 16, 2024 Commercial sugar substitutes have been used since the late 1800s when saccharin was accidentally developed by a chemist at Johns Hopkins University. Due to widespread sugar rationing during World Wars I and II, saccharin grew in popularity. In more recent times, the...
Post
Nutritional Psychiatry: Does It Exist?
Perspective > MDedgeCOMMENTARY Andrew J. Rosenfeld, MD Disclosures August 25, 2023 Matt was diagnosed with ADHD combined type when he was 6 years old. Given his age, the family was reluctant to try medications, but after a couple years of parenting classes and reward charts, the parents requested a stimulant. He had significant improvement in...
Post
On Second Thought: The Truth About Beta-Blockers
COMMENTARY Christopher Labos, MD CM, MSc, FRCPC DISCLOSURES | August 08, 2024 If this is what your kitchen looks like, you may not be good with change. By the end of this video, I’m going to explain to you why carpets in your kitchen are a bad idea, and why your patient may not need...
Post
Yes, you should be worried about bird flu
The views expressed by contributors are their own and not the view of The Hill by Gene Baur, opinion contributor – 08/05/24 4:30 PM ET Cambridge, MA – May 14: From left, Jon Arizti Sanz, PhD, Postdoctoral Fellow with Liam Alec Stenson Ortiz, research associate working in the lab. The Broad institute, Sabeti Lab is...
Post
Is Semaglutide the ‘New Statin’? Not So Fast
Medscape Diabetes & EndocrinologyCOMMENTARY Kevin Fernando, MBChB, MSc Diabetes, BSc DISCLOSURES | June 03, 2024 There has been much hyperbole since the presentation of results from the SELECT cardiovascular outcomes trial (CVOT) at this year’s European Congress on Obesity, which led many to herald semaglutide as the “new statin.” In the SELECT CVOT, participants with...
Post
New First-Line Therapies for Migraine
Medscape Family Medicine > Clinical Guidelines for Primary CareCOMMENTARY Neil Skolnik, MD DISCLOSURES | August 07, 2024 This transcript has been edited for clarity. I’m Dr Neil Skolnik and today we are going to talk about the position statement from the American Headache Society (AHS) “Calcitonin Gene-Related Peptide-Targeting Therapies Are a First-Line Option for the...
Post
Drug pricing
Price competition’s society-altering test Illustration: Aïda Amer/Axios Two facts about GLP-1s tend to dominate conversations: Their effectiveness is almost too good to be true, and if everyone who could benefit from them received them — at least at current prices — the cost would be prohibitively expensive. Why it matters: With the development pipeline chock-full...
Post
Phasing out the ‘D-word’
from STAT:First Opinion By Mike ZuendelAug. 5, 2024 Reprints As I roamed the meeting rooms and halls of the Alzheimer’s Association International Conference in Philadelphia last week, I kept hearing a word — dementia — I’ve come to loathe as someone with early Alzheimer’s. The use of this term goes back as far as the...
Post
Almost 50% of Global Dementia Cases May Be Preventable
Medscape Medical News > Conference News > AAIC 2024 Megan Brooks July 31, 2024 PHILADELPHIA – Nearly half of dementia cases worldwide could theoretically be prevented or delayed by eliminating 14 modifiable risk factors during an individual’s lifetime, a report from the Lancet Commission on dementia prevention, intervention, and care. The report adds two new...